These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 1625800)

  • 21. Amino-terminus truncated apolipoprotein E is the major species in amyloid deposits in Alzheimer's disease-affected brains: a possible role for apolipoprotein E in Alzheimer's disease.
    Aizawa Y; Fukatsu R; Takamaru Y; Tsuzuki K; Chiba H; Kobayashi K; Fujii N; Takahata N
    Brain Res; 1997 Sep; 768(1-2):208-14. PubMed ID: 9369317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid beta.
    Zlokovic BV; Martel CL; Mackic JB; Matsubara E; Wisniewski T; McComb JG; Frangione B; Ghiso J
    Biochem Biophys Res Commun; 1994 Dec; 205(2):1431-7. PubMed ID: 7802679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease.
    Bales KR; Verina T; Cummins DJ; Du Y; Dodel RC; Saura J; Fishman CE; DeLong CA; Piccardo P; Petegnief V; Ghetti B; Paul SM
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15233-8. PubMed ID: 10611368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relation of proteoglycans, serum amyloid P and apo E to amyloidosis current status, 2000.
    Kisilevsky R
    Amyloid; 2000 Mar; 7(1):23-5. PubMed ID: 10842701
    [No Abstract]   [Full Text] [Related]  

  • 25. Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid.
    Wisniewski T; Golabek A; Matsubara E; Ghiso J; Frangione B
    Biochem Biophys Res Commun; 1993 Apr; 192(2):359-65. PubMed ID: 8484748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formation and function of apolipoprotein E-containing lipoproteins in the nervous system.
    Vance JE; Hayashi H
    Biochim Biophys Acta; 2010 Aug; 1801(8):806-18. PubMed ID: 20170744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conformational mimicry in Alzheimer's disease. Role of apolipoproteins in amyloidogenesis.
    Wisniewski T; Golabek AA; Kida E; Wisniewski KE; Frangione B
    Am J Pathol; 1995 Aug; 147(2):238-44. PubMed ID: 7639323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein E increases the fibrillogenic potential of synthetic peptides derived from Alzheimer's, gelsolin and AA amyloids.
    Soto C; Castaño EM; Prelli F; Kumar RA; Baumann M
    FEBS Lett; 1995 Sep; 371(2):110-4. PubMed ID: 7672107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relative efficacies of amyloid beta peptide (A beta) binding proteins in A beta aggregation.
    Webster S; Rogers J
    J Neurosci Res; 1996 Oct; 46(1):58-66. PubMed ID: 8892106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical localization of apolipoprotein E in renal amyloidosis.
    Taniguchi Y; Yorioka N; Yamashita K; Oda H; Nie LF; Ye Yeu XF; Okushin S; Nishida Y; Kushihata S; Yamakido M
    Hiroshima J Med Sci; 1996 Mar; 45(1):11-4. PubMed ID: 8984100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain expression of apolipoproteins E, J, and A-I in Alzheimer's disease.
    Harr SD; Uint L; Hollister R; Hyman BT; Mendez AJ
    J Neurochem; 1996 Jun; 66(6):2429-35. PubMed ID: 8632166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis.
    Coria F; Castaño E; Prelli F; Larrondo-Lillo M; van Duinen S; Shelanski ML; Frangione B
    Lab Invest; 1988 Apr; 58(4):454-8. PubMed ID: 2965774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of apolipoprotein E with murine amyloid A protein amyloid.
    Kindy MS; King AR; Perry G; de Beer MC; de Beer FC
    Lab Invest; 1995 Oct; 73(4):469-75. PubMed ID: 7474917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycosaminoglycans inhibit neurodegenerative effects of serum amyloid P component in vitro.
    Urbányi Z; Forrai E; Sárvári M; Likó I; Illés J; Pázmány T
    Neurochem Int; 2005 May; 46(6):471-7. PubMed ID: 15769549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer's disease.
    Hondius DC; Eigenhuis KN; Morrema THJ; van der Schors RC; van Nierop P; Bugiani M; Li KW; Hoozemans JJM; Smit AB; Rozemuller AJM
    Acta Neuropathol Commun; 2018 Jun; 6(1):46. PubMed ID: 29860944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice.
    Sadowski M; Pankiewicz J; Scholtzova H; Ripellino JA; Li Y; Schmidt SD; Mathews PM; Fryer JD; Holtzman DM; Sigurdsson EM; Wisniewski T
    Am J Pathol; 2004 Sep; 165(3):937-48. PubMed ID: 15331417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral amyloid angiopathy associated with hemorrhage: immunohistochemical study of 41 biopsy cases.
    Izumihara A; Ishihara T; Hoshii Y; Ito H
    Neurol Med Chir (Tokyo); 2001 Oct; 41(10):471-7; discussion 477-8. PubMed ID: 11760381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
    de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM
    J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcium-dependent and -independent binding of the pentraxin serum amyloid P component to glycosaminoglycans and amyloid proteins: enhanced binding at slightly acid pH.
    Danielsen B; Sørensen IJ; Nybo M; Nielsen EH; Kaplan B; Svehag SE
    Biochim Biophys Acta; 1997 Apr; 1339(1):73-8. PubMed ID: 9165101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in amyloid precursor protein and apolipoprotein E immunoreactivity following ischemic brain injury in rat with long-term survival: influence of idebenone treatment.
    Pluta R; Barcikowska M; Debicki G; Ryba M; Januszewski S
    Neurosci Lett; 1997 Aug; 232(2):95-8. PubMed ID: 9302095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.